Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2021

Aug 17, 2021

BUY
$67.66 - $84.76 $132,545 - $166,044
1,959 Added 33.95%
7,730 $647,000
Q3 2018

Nov 16, 2018

BUY
$46.76 - $51.24 $269,851 - $295,706
5,771 New
5,771 $455,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $198B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Omni Star Financial Group, Inc. Portfolio

Follow Omni Star Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omni Star Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Omni Star Financial Group, Inc. with notifications on news.